BOSTON – (November 29, 2017) – Scientists at Joslin Diabetes Center have taken another step toward solving a long-standing puzzle about heart health in type 2 diabetes, with a finding that eventually may point towards more personalized patient...
29-Nov-2017 2:40 PM EST Add to Favorites
BOSTON – (October 3, 2017) – If you’re one of the two billion people in the world who are over-weight or obese, or the one billion people with fatty liver disease, your doctor’s first advice is to cut calories—and especially to cut down on...
4-Oct-2017 11:05 AM EDT Add to Favorites
Joslin’s research involves a wide variety of biologic disciplines ranging from the most basic model systems to studies of pathophysiology in animal models and humans to the evaluation of new therapies in patients. The primary aim of the Joslin DRC...
3-Oct-2017 10:05 AM EDT Add to Favorites
Researchers at Joslin Diabetes Center have identified an unexpected natural protective factor against chronic inflammation that drives cardiovascular disease in type 2 diabetes.
20-Sep-2017 11:05 AM EDT Add to Favorites
“People are living longer with type 1 diabetes, and the onset of complications is taking longer,” says Hillary Keenan, Ph.D., a Joslin Diabetes Center Assistant Investigator and co-Principal Investigator on the Joslin 50-Year Medalist Study.
21-Aug-2017 10:00 AM EDT Add to Favorites
Lloyd Paul Aiello, M.D., Ph.D., Receives the 2017 JDRF Excellence in Clinical Research Award for Type 1 Diabetes Research
The award recognizes Aiello's research to determine the underlying biochemistry and molecular mechanisms of diabetic retinopathies, then develop and test novel therapeutic interventions through rigorous translational and clinical trial research.
13-Jun-2017 1:05 PM EDT Add to Favorites
Joslin Diabetes Center has established a Center for Cell-Based Therapy for Diabetes (CCTD), the goal of which is to lead the development and translation of cell-based interventions to treat and cure diabetes and its complications.
9-Jun-2017 12:15 PM EDT Add to Favorites
Doctors rely mostly on two biomarkers -- urinary albumin to creatinine ratio (ACR) and estimated glomerular filtration rate -- to identify those at higher risk of kidney failure.
But researchers say those criteria miss a large proportion of...
18-Apr-2017 4:05 PM EDT Add to Favorites
Diabetes & Breast Cancer - Elizabeth Halprin MD Talks About the Important Struggle to Balance Both Diseases
12-Oct-2017 10:05 AM EDT
Dr. Lori Laffel, Chief of Pediatrics at Joslin Diabetes Center, Available to Comment on Type 1 Diabetes and Life Expectancy Studies
6-Jan-2015 11:00 AM EST
Lori Laffel, M.D., MPH, Chief of the Pediatric, Adolescent and Young Adult Section at Joslin Diabetes Center and Associate Professor of Pediatrics at Harvard Medical School, oversees the largest pediatric diabetes clinic in New England has over 25...
15-Aug-2014 8:00 AM EDT
The International Diabetes Federation now recommends that surgery be considered as a treatment for obese patients with type 2 diabetes. Dr. Allison Goldfine, head of clinical research at Joslin Diabetes Center, is available for comment.
29-Mar-2011 9:00 AM EDT
Emerging technologies such as continuous glucose monitoring (CGM) are helping people with type 1 diabetes manage their condition—what are the next steps? Howard Wolpert, M.D., of Joslin Diabetes Center discusses his current research and the global...
1-Oct-2010 1:00 PM EDT